From Name:
From Email:
To Name:
To Email:

Optional Message:


New Clinical Trial Shows Second Generation Drug-Eluting Stents Are Safe And Effective

from SCAI via EurekAlert

Results of the PERSPECTIVE trial were presented today as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions. The PERSPECTIVE study is a prospective, single-center rigorously performed clinical trial and reports on one-year outcomes of patients undergoing chronic total occlusion percutaneous coronary intervention treated with Zotarolimus-Eluting Stents. The ZES included in the study were manufactured by Medtronic and represent a modern, newer generation drug-eluting stent. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063